“Association Between Visceral Adiposity, Insulin Resistance, And Fatty Liver In Patients With Type 2 Diabetes Mellitus” (2023) Journal of Pharmaceutical Negative Results, pp. 3903–3909. doi:10.47750/pnr.2023.14.03.489.